John Dobak - Jun 1, 2021 Form 4 Insider Report for DermTech, Inc. (DMTK)

Role
Chief Executive Officer, Director
Signature
/s/ Jason S. Miller, attorney-in-fact
Stock symbol
DMTK
Transactions as of
Jun 1, 2021
Transactions value $
-$500,643
Form type
4
Date filed
6/3/2021, 08:19 PM
Next filing
Jun 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMTK Common Stock Sale -$119K -2.97K -0.61% $40.22* 487K Jun 1, 2021 Direct F1, F2, F3
transaction DMTK Common Stock Sale -$381K -9.53K -1.96% $40.00* 478K Jun 2, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $40.00 to $40.55, inclusive. The reported price reflects the weighted-average sale price.
F3 The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4.